Strasbourg, France

Jean-Luc Imler


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 110(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Luc Imler from Strasbourg, France

Introduction: Jean-Luc Imler is a notable inventor based in Strasbourg, France, recognized for his contributions to the field of biotechnology. With a noteworthy portfolio of four patents, he has made significant advancements in the development of defective adenoviruses, which have potential applications in therapeutic settings.

Latest Patents: Among his latest patents, Jean-Luc Imler has developed novel defective adenoviruses geared towards the transfer and expression of exogenous nucleotide sequences in host cells or organisms. These inventions not only pertain to the defective adenoviruses but also include unique complementation lines, highlighting the innovative processes for their preparation. This work is crucial for developing pharmaceutical compositions with therapeutic potential, indicating a profound impact on medical research and treatments.

Career Highlights: Jean-Luc Imler is affiliated with Transgene S.A., a company specializing in the development of immunotherapy solutions for cancer treatment. His work at Transgene has positioned him at the forefront of biopharmaceutical innovation, where he harnesses his expertise to drive advancements in genetic therapies.

Collaborations: Throughout his career, Jean-Luc Imler has collaborated with esteemed colleagues such as Majid Mehtali and Andrea Pavirani. These collaborations have played a vital role in propelling research efforts forward, further enhancing the sophistication of the scientific developments they pursue.

Conclusion: Jean-Luc Imler's contributions to biotechnology, particularly in the development of defective adenoviruses, represent a significant leap in the field. His four patents not only showcase his inventive prowess but also underline the collaborative efforts that fuel innovation within the industry. As the landscape of medical therapies continues to evolve, Jean-Luc Imler stands out as a key figure in pioneering advancements that may shape the future of health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…